Veracyte, Inc. (VCYT) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGM. Market cap 3.51B USD. 52-week range 29.45 to 60.91 USD. Trailing P/E 31.1. Data as of 2026-10-09.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was ...